Improvement of the antibacterial activity of daptomycin-loaded polymeric microparticles by Eudragit RL 100: an assessment by isothermal microcalorimetry

Int J Pharm. 2015 May 15;485(1-2):171-82. doi: 10.1016/j.ijpharm.2015.03.016. Epub 2015 Mar 12.

Abstract

The aim of the present study was to develop novel daptomycin-loaded acrylic microparticles with improved release profiles and antibacterial activity against two clinically relevant methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains (MSSA and MRSA, respectively). Daptomycin was encapsulated into poly(methyl methacrylate) (PMMA) and PMMA-Eudragit RL 100 (EUD) microparticles by a double emulsion-solvent evaporation method. For comparison purposes similar formulations were prepared with vancomycin. Particle morphology, size distribution, encapsulation efficiency, surface charge, physicochemical properties, in vitro release and biocompatibility were assessed. Particles exhibited a micrometer size and a spherical morphology. The addition of EUD to the formulation caused a shift in the surface charge of the particles from negative zeta potential values (100% PMMA formulations) to strongly positive. It also improved daptomycin encapsulation efficiency and release, whereas vancomycin encapsulation and release were strongly hindered. Plain and antibiotic-loaded particles presented comparable biocompatibility profiles. The antibacterial activity of the particles was assessed by isothermal microcalorimetry against both MSSA and MRSA. Daptomycin-loaded PMMA-EUD particles presented the highest antibacterial activity against both strains. The addition of 30% EUD to the daptomycin-loaded PMMA particles caused a 40- and 20-fold decrease in the minimum inhibitory (MIC) and bactericidal concentration (MBC) values, respectively, when compared to the 100% PMMA formulations. On the other hand, vancomycin-loaded microparticles presented the highest antibacterial activity in PMMA particles. Unlike conventional methods, isothermal microcalorimetry proved to be a real-time, sensitive and accurate method for assessment of antibacterial activity of antibiotic-loaded polymeric microparticles. Finally, the addition of EUD to formulations proved to be a powerful strategy to improve daptomycin encapsulation efficiency and release, and consequently improving the microparticles activity against two relevant S. aureus strains.

Keywords: Controlled release; Daptomycin; Eudragit; Isothermal microcalorimetry; Microencapsulation; PMMA; Vancomycin.

Publication types

  • Comparative Study
  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acrylic Resins / chemistry*
  • Acrylic Resins / toxicity
  • Animals
  • Anti-Bacterial Agents / chemistry
  • Anti-Bacterial Agents / pharmacology*
  • Anti-Bacterial Agents / toxicity
  • Calorimetry / methods*
  • Calorimetry, Differential Scanning
  • Cell Line
  • Cell Survival / drug effects
  • Chemistry, Pharmaceutical
  • Daptomycin / chemistry
  • Daptomycin / pharmacology*
  • Daptomycin / toxicity
  • Delayed-Action Preparations
  • Dose-Response Relationship, Drug
  • Drug Carriers*
  • Kinetics
  • Methicillin-Resistant Staphylococcus aureus / drug effects
  • Methicillin-Resistant Staphylococcus aureus / growth & development
  • Mice
  • Microbial Sensitivity Tests
  • Particle Size
  • Polymethyl Methacrylate / chemistry*
  • Polymethyl Methacrylate / toxicity
  • Solubility
  • Spectroscopy, Fourier Transform Infrared
  • Staphylococcus aureus / drug effects
  • Staphylococcus aureus / growth & development
  • Surface Properties
  • Technology, Pharmaceutical / methods*
  • Vancomycin / pharmacology

Substances

  • Acrylic Resins
  • Anti-Bacterial Agents
  • Delayed-Action Preparations
  • Drug Carriers
  • Eudragit RS
  • Vancomycin
  • Polymethyl Methacrylate
  • Daptomycin